Patients and Methods
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Energy balance and cancer prognosis: breast cancer.in: McTiernan A Cancer Prevention and Management Through Exercise and Weight Control. CRC Press, Boca Raton, FL2006: 405-435
- Fasting insulin and outcome in early stage breast cancer: results of a prospective cohort study.J Clin Oncol. 2002; 20: 42-51
- Insulin, macronutrient intake, and physical activity: Are potential indicators of insulin resistance associated with mortality from breast cancer?.Cancer Epidemiol Biomarkers Prev. 2004; 13: 1163-1172
- Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial.J Clin Oncol. 2006; 24 (Abstract 524).: 9s
- Metabolic syndrome as a prognostic factor for breast cancer recurrences.Int J Cancer. 2006; 119: 236-238
- The insulin resistance syndrome: definition and dietary approaches to treatment.Ann Rev Nutr. 2005; 25: 391-406
- Obesity and insulin resistance.in: McTiernan A Cancer Prevention and Management Through Exercise and Weight Control. CRC Press, Boca Raton, FL2006: 301-316
- Insulin and hybrid/IGF receptors are major regulators of breast cancer cells.Breast Dis. 2003; 17: 73-89
- Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.Breast Cancer Res Treat. 2007; 106: 39-47
- Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.Exp Clin Endocrinol Diabetes. 2001; 109: S265-S287
- Rosiglitazone but not metformin enhances insulin-and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.Diabetes. 2002; 51: 3479-3485
- Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.Diabetes. 2003; 52: 283-290
- The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.Science. 2005; 310: 1642-1646
- Medicine. Cancer-suppressing enzyme adds a link to type 2 diabetes.Science. 2005; 310: 1259
- Metformin and reduced risk of cancer in diabetic patients.BMJ. 2005; 330: 1304-1305
- Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.Diabetes Care. 2006; 29: 254-258
- The effects of metformin on pathologic complete response (pCR) rates in diabetic breast cancer (BC) patients receiving neoadjuvant therapy (NST).J Clin Oncol. 2008; 26 (Abstract 528).: 13s
- Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.Exp Gerontol. 2005; 40: 685-693
- Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice.Bull Exp Biol Med. 2005; 139: 721-723
- The assessment of insulin resistance in man.Diabetes Med. 2004; 19: 527-534
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care. 2000; 23: 57-63
Glucophage (metformin hydrochloride) [product monograph]. Sanofi-aventis Canada, Inc., Version 2.0, June 20, 2006.
- Dietary fat reduction and breast cancer outcomes: interim efficacy results from the Women's Intervention Nutrition Study.J Natl Cancer Inst. 2006; 98: 1767-1776
- Influence of a diet very high in vegetables, fruits and fiber and low in fat on prognosis following treatment for breast cancer; the Women's Healthy Eating and Living (WHEL) randomized trial.JAMA. 2007; 298: 289-298
- Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.Cancer Res. 2006; 66: 10269-10273
- Metformin inhibitis mammalian target of rapamycin-dependent translation initiation in breast cancer cells.Cancer Res. 2007; 67: 10804-10812
- Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?.J Clin Oncol. 2008; 26: 833-834
- Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.J Clin Oncol. 2008; 26: 907-912
Electronic forwarding or copying is a violation of US and International Copyright Laws.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by CIG Media Group, LP, ISSN #1526-8209, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.